Pharmaceutical Statistics

Cover image for Vol. 15 Issue 4

Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz

Impact Factor: 1.235

ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 208/253 (Pharmacology & Pharmacy)

Online ISSN: 1539-1612

Recently Published Issues

See all

Welcome to the new Editor-in-Chief

We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.

David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.

David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.

David Morgan

Recently Published Articles

  1. Effect of design specifications in dose-finding trials for combination therapies in oncology

    Akihiro Hirakawa, Hiroyuki Sato and Masahiko Gosho

    Version of Record online: 19 AUG 2016 | DOI: 10.1002/pst.1770

  2. Dynamical Biostatistical Models

    Jixian Wang

    Version of Record online: 15 AUG 2016 | DOI: 10.1002/pst.1772

  3. Trimmed means for symptom trials with dropouts

    Thomas Permutt and Feng Li

    Version of Record online: 15 AUG 2016 | DOI: 10.1002/pst.1768

  4. Model averaging in concentration–QT analyses

    Bernard Sébastien, David Hoffman, Clémence Rigaux, Franck Pellissier and Jérôme Msihid

    Version of Record online: 5 AUG 2016 | DOI: 10.1002/pst.1766